How World-Class Filmmaker Andrey Zvyagintsev Came Back to Life for ‘Minotaur’
Andrey Zvyagintsev, the acclaimed Russian filmmaker, returned to Cannes with his new film 'Minotaur' after recovering from a severe illness. He faced significant health challenges following a COVID infection and subsequent complications, which left him paralyzed for a year. Despite these obstacles, he managed to complete his first film in nearly a decade, adapting a classic thriller while living in Paris due to the political climate in Russia.
- ▪Andrey Zvyagintsev was in a medically induced coma for 14 days after contracting COVID-19 and reacting badly to the Sputnik vaccine.
- ▪He was paralyzed for a year due to Guillain-Barré Syndrome but has since regained some mobility.
- ▪Zvyagintsev's new film 'Minotaur' is his first release since 2017's 'Loveless' and was shot outside of Russia.
IndieWire files mainly under film tv. We currently carry 117 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | IndieWire |
| Canonical URL | https://www.indiewire.com/features/interviews/andrey-svyagintsev-cannes-interview-minotaur-1235195741/ |
| Publication time | Fri, 22 May 2026 18:00:00 +0000 |
| Retrieval time | 2026-05-22T18:02:02.754Z |
| Last seen | 2026-05-22T18:02:02.754Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | a0p9RBKeHuCO |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
World-class Russian filmmaker Andrey Zvyagintsev (“Leviathan”) returned to the Croisette this year in Cannes competition with “Minotaur,” having recovered from a near-fatal illness. After contracting a severe case of COVID in 2021, he reacted badly to the Sputnik vaccine and was put into a medically induced coma for 14 days. When he came out of it, his arms and legs were paralyzed due to Guillain-Barré Syndrome. He lay flat on his back for a year. When he left the hospital in Germany in 2022, as he told me while at Cannes this year, he was in a wheelchair. While he says he hasn’t watched TV for 20 years now, “I watched a lot of films online,” he said through an interpreter on the roof of the Palais. “I read some things.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at IndieWire.
Discussion
0 commentsMore from IndieWire
